суббота, 18 июня 2016 г.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Rating Reaffirmed by RBC Capital

Valeant Pharmaceuticals Intl Inc (VRX) Stock Rating Reaffirmed by RBC Capital


's stock had its "hold" rating reissued by research analysts at RBC Capital in a note issued to investors on Thursday. A number of hedge funds have recently added to or reduced their stakes in VRX.



from Biotech News